Rajendra K Tangirala

Title: Rajendra K Tangirala: Innovator in Metabolic Disease Treatments

Introduction

Rajendra K Tangirala is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of metabolic diseases through his innovative research and patented methods. His work focuses on utilizing LXR compounds to address various health issues, including cholesterol management and diabetes treatment.

Latest Patents

Rajendra K Tangirala holds a patent titled "Methods for affecting various diseases utilizing LXR compounds." This invention relates to methods for elevating high-density lipoprotein (HDL) plasma levels, decreasing the absorption of dietary cholesterol in the intestine, and reducing low-density lipoprotein (LDL) plasma levels. The patent also discusses the conversion of cholesterol to bile acids using LXRβ selective agonists, which can be used to treat metabolic diseases, type II diabetes, and obesity.

Career Highlights

Rajendra K Tangirala is associated with X-ceptor Therapeutics, Inc., where he continues to advance his research in metabolic health. His work has the potential to significantly impact the treatment of cardiovascular complications and insulin resistance associated with type II diabetes.

Collaborations

He has collaborated with notable colleagues, including Ira Glenn Schulman and Eric D Bischoff, to further enhance the research and development of innovative treatments in his field.

Conclusion

Rajendra K Tangirala's contributions to the field of metabolic diseases through his patented methods demonstrate his commitment to improving health outcomes. His innovative approaches have the potential to transform the treatment landscape for various diseases.